Article Text

Download PDFPDF

Assessing the impact of interventions in sleep-disordered breathing
S16 Detection of sleep-disordered breathing in chronic heart failure patients: utility of heart rate variability versus pulse oximetry?
  1. N R Ward1,
  2. M R Cowie2,
  3. S D Rosen2,
  4. V R Roldao1,
  5. J Hooper2,
  6. T A McDonagh2,
  7. A K Simonds1,
  8. M J Morrell1
  1. 1Clinical and Academic Unit of Sleep and Breathing, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, UK
  2. 2Clinical Cardiology, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, UK


Introduction and Objectives Sleep-disordered breathing (SDB) is a frequent comorbidity in chronic heart failure (CHF). Patients are often asymptomatic and sleep studies may be required for SDB diagnosis. Our department has previously reported that %VLFI component of Heart Rate Variability (HRV) is correlated with apnoea-hypopnoea index (AHI) in CHF (r=0.52). Thus, we tested the hypotheses that %VLFI component of HRV, or pulse oximetry, can be used to rule out SDB in patients with CHF.

Methods Stable CHF patients attending cardiology clinics were enrolled, irrespective of cause or severity of CHF. Patients were studied using polysomnography, simultaneous ambulatory electrocardiography and pulse oximetry. SDB was defined as AHI ≥15.0/h, measured by polysomnogram. Fourier analysis of the electrocardiogram was used to measure %VLFI component of HRV, with a cutoff ≥2.23% to indicate SDB. The oxygen desaturation index (ODI) ≥3% was measured by pulse oximeter, with a cutoff >7.5 desaturations/h to indicate SDB. Diagnostic performance of %VLFI and ODI≥3% were calculated, with the polysomnogram as reference standard for SDB diagnosis.

Results 180 CHF patients were studied, seven were excluded due to insufficient sleep (<200 min). In 173 CHF patients (mean (SD) age 66.9 (13.0) years; 86% male; Epworth Sleepiness Scale 7.6 (4.3); NYHA 2.1 (0.6); median (IQR) BNP 118 (55–239) pg/ml), SDB was present in 77 (45%) patients with mean AHI 32.4 (18.2)/h. %VLFI was measured in 77 (45%) patients: in CHF patients with SDB (n=36), mean %VLFI was 3.13% (2.4) compared to 3.25% (2.6) in patients without SDB (n=41). Cardiac pacing, atrial fibrillation and frequent ectopy prevented %VLFI measurement in the remainder. ODI ≥3% was measured in 171 patients: in CHF patients with SDB (n=76), mean ODI ≥3% was 29.2 (17.2)/h compared to 10.2 (6.4)/h in patients without SDB (n=95).

Conclusion The %VLFI component of HRV has no utility to screen for SDB in patients with CHF. Moreover, it could not be measured in more than half of this cohort of patients. In contrast, the high sensitivity and negative predictive value of the ODI ≥3% suggest pulse oximetry is a valuable tool to rule out SDB in CHF patients.

Abstract S16 Table 1

Diagnostic performance of %VLFI and ODI >3% for detection of SDB in CHF patients

Statistics from


  • Funding This study was funded by the British Heart Foundation.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.